Comparative Analysis of CpG Islands among HBV Genotypes

DNA methylation is being increasingly recognized to play a role in regulation of hepatitis B virus (HBV) gene expression. The aim of this study was to compare the CpG island distribution among different HBV genotypes. We analyzed 176 full-length HBV genomic sequences obtained from the GenBank database, belonging to genotypes A through J, to identify the CpG islands in the HBV genomes. Our results showed that while 79 out of 176 sequences contained three conventional CpG islands (I–III) as previously described, 83 HBV sequences harbored only two of the three known islands. Novel CpG islands were identified in the remaining 14 HBV isolates and named as CpG island IV, V, and VI. Among the eight known HBV genotypes and two putative genotypes, while HBV genomes containing three CpG islands were predominant in genotypes A, B, D, E, and I; genotypes C, F, G, and H tended to contain only two CpG islands (II and III). In conclusion, the CpG islands, which are potential targets for DNA methylation mediated by the host functions, differ among HBV genotypes, and these genotype-specific differences in CpG island distribution could provide new insights into the understanding of epigenetic regulation of HBV gene expression and hepatitis B disease outcome.     

Adenosine A1-Receptors Modulate mTOR Signaling to Regulate White Matter Inflammatory Lesions Induced by Chronic Cerebral Hypoperfusion

We sought to investigate the role of the adenosine A1 receptors (A1ARs) in white matter lesions under chronic cerebral hypoperfusion (CCH) and explore the potential repair mechanisms by activation of the receptors. A right unilateral common carotid artery occlusion (rUCCAO) method was used to construct a CCH model. 2-chloro-N6-cyclopentyladenosine (CCPA), a specific agonist of A1ARs, was used to explore the biological mechanisms of repair in white matter lesions under CCH. The expression of mammalian target of rapamycin (mTOR), phosphorylation of mTOR (P-mTOR), myelin basic protein (MBP, a marker of white matter myelination) were detected by Western-blot. Pro-inflammatory cytokine tumor necrosis factor-α (TNF-α) and anti-inflammatory cytokine interleukin-10 (IL-10) levels were determined by ELISA. Compared with the control groups on week 2, 4 and 6, in CCPA-treated groups, the ratio of P-mTOR/mTOR, expression of MBP and IL-10 increased markedly, while the expression of TNF-α reduced at week 6. In conclusion, A1ARs appears to reduce inflammation in white matter via the mTOR signaling pathway in the rUCCAO mice. Therefore, A1ARs may serve as a therapeutic target during the repair of white matter lesions under CCH.     

天然雌核发育贵州普安鲫(A型)染色体组型的初步研究

普安鲫(Carassius auratus)原产于贵州省普安县青山镇一带的天然水体中,它有3个不同类型(A、B和C型)的种群。目前除了A型在野外未见雄性个体外,B和C型都是两性型种群,它们同地共栖,且行天然雌核发育。       

Fine Tuning Electronic Structure of Catalysts through Atomic Engineering for Enhanced Hydrogen Evolution

An efficient, durable, and low‐cost hydrogen evolution reaction (HER) catalyst is an essential requirement for practical hydrogen production. Herein, an effective approach to facilitate the HER kinetics of molybdenum carbide (Mo₂C) electrocatalysts is presented by tuning its electronic structure through atomic engineering of nitrogen implantation. Starting from the organoimido‐derivatized polyoxometalate nanoclusters with inherent Mo? N bonds, the formation of N‐implanted Mo₂C (N@Mo₂C) nanocrystals with perfectly adjustable amounts of N atoms is demonstrated. The optimized N@Mo₂C electrocatalyst exhibits remarkable HER performance and good stability over 20 h in both acid and basic electrolytes. Further density functional theory calculations show that engineering suitable nitrogen atoms into Mo₂C can regulate its electronic structure well and decrease Mo? H strength, leading to a great enhancement of the HER activity. It could be believed that this ligand‐controlled atomic engineering strategy might influence the overall catalyst design strategy for engineering the activation sites of nonprecious metal catalysts for energy conversions.     

Alteration of liver glycopatterns during cirrhosis and tumor progression induced by HBV

The incidence of hepatocellular carcinoma (HCC) is closely correlated with hepatitis B virus (HBV)-induced liver cirrhosis. Structural changes in the glycans of serum and tissue proteins are reliable indicators of liver damage. However, little is known about the alteration of liver glycopatterns during cirrhosis and tumor progression induced by HBV infection. This study compared the differential expression of liver glycopatterns in 7 sets of normal pericarcinomatous tissues (PCTs), cirrhotic, and tumor tissues from patients with liver cirrhosis and HCC induced by HBV using lectin microarrays. Fluorescence-based lectin histochemistry and lectin blotting were further utilized to validate and assess the expression and distribution of certain glycans in 9 sets of corresponding liver tissue sections. Eight lectins (e.g., Jacalin and AAL) revealed significant difference in cirrhotic tissues versus PCTs. Eleven lectins (e.g., EEL and SJA) showed significant alteration during cirrhotic and tumor progression. The expression of Galα1-3(Fucα1-2)Gal (EEL) and fucosyltransferase 1 was mainly increasing in the cytoplasm of hepatocytes during PCTs-cirrhotic-tumor tissues progression, while the expression of T antigen (ACA and PNA) was decreased sharply in cytoplasm of tumor hepatocytes. Understanding the precision alteration of liver glycopatterns related to the development of hepatitis, cirrhosis, and tumor induced by HBV infection may help elucidate the molecular mechanisms underlying the progression of chronic liver diseases and develop new antineoplastic therapeutic strategies.     

Deoxycholic acid (DCA) confers an intestinal phenotype on esophageal squamous epithelium via induction of the stemness-associated reprogramming factors OCT4 and SOX2

Barrett's esophagus (BE) is essentially a metaplasia in which the normal stratified squamous epithelium is replaced by columnar epithelium. This study focuses on the involvement of OCT4 and SOX2, 2 key cell-reprogramming factors, in the deoxycholic acid (DCA)-induced expression of the intestinal hallmarks Cdx2 and MUC2 using both in vivo and in vitro models. Up-regulated expression of OCT4 and down-regulated expression of SOX2 were observed in BE compared with normal esophagus and esophagitis. Consistent with the data in vivo, DCA induced time-dependent expression of OCT4 at both the mRNA and protein levels and decreased nuclear expression of SOX2 in Het-1A cells. Down-regulation of OCT4 expression by siRNA abrogated DCA-induced expression of Cdx2 and MUC2, whereas siRNA against SOX2 significantly upregulated the expression of both Cdx2 and MUC2. Our data indicate that both OCT4 and SOX2 play important roles in the development of BE triggered by bile acid reflux.     

青鱼Mylopharygodon piceus出血病的初步研究

青鱼出血病是危害青色最严重的疾病之一,尤以二龄为甚。通过人工注射免疫后,可使青鱼的成活率由原来20％左右提高至60—90％,个别的可达98.98％。通过病鱼肾脏组织超薄切片电镜观察,首次发现病毒颗粒(直径为50—56毫微米)的存在,经0.15微米孔径的滤膜过滤的病原悬液可反复在鱼体内传3—4代,使健康鱼发病。因此,认为青鱼出血病是病毒引起的疾病。     

绿色高效液相色谱法分析四种虫草药材的游离和总甾醇含量

虫草类药材采用85%乙醇超声提取游离甾醇、采用0.5 mol/L氢氧化钾-乙醇溶液回流提取总甾醇,并用绿色溶剂(乙醇和水)固相萃取法纯化分析溶液。用HPLC-ELSD法测定麦角甾醇、胆甾醇和谷甾醇的含量,色谱柱为Poroshell 120 EC-C₁₈ (100 mm×4.6 mm, 2.7 μm),绿色流动相乙醇-水(89:11),流速为0.5 mL/min,结果表明所建立的分析方法3种甾醇成分在考察的浓度范围内,线性关系好、精密度和准确度高。20批虫草类样品均含结合型甾醇和游离型甾醇;冬虫夏草繁育品与野生品均含3种甾醇,两者含量相当;凉山虫草(野生品)、蛹虫草(培植品)、蝉花(野生品)可检测到麦角甾醇。该方法可有效鉴别冬虫夏草和其他3种虫草产品,为虫草类产品质量评价提升提供了依据。     

IL-2-engineered nano-APC effectively activates viral antigen-mediated T cell responses from chronic hepatitis B virus-infected patients

Impaired function of virus-specific T cells resulting from virus persistence is one of the major mechanisms underlying the development of chronic hepatitis B viral infection. Previously, we found that IL-2 can restore the effector function of T cells rendered tolerant by Ag persistence. However, systemic administration of IL-2 induces organ pathology and expansion of T regulatory cells. In this study, we show that nano-APC with engineered HLA alleles and IL-2 deliver peptide-MHC complexes, costimulatory molecules, and IL-2 to Ag-responding T cells, resulting in enhanced expression of CD25 and activation of TCR signaling pathways, while suppressing PD-1 expression on viral-responding CD8 T cells from chronic hepatitis B virus patients. The enhanced activation of CD4 and CD8 T cells induced by IL-2-nano-APC was Ag dependent and IL-2-nano-APC did not affect T regulatory cells. At a size of 500 nm, the nano-APC effectively induce immune synapse formation on Ag-specific T cells and accumulate as free particles in the lymphoid organs. These attributes of IL-2-nano-APC or other bioadjuvant-engineered nano-APC have profound implications for their use as a therapeutic strategy in the treatment of chronic hepatitis B virus infection or other chronic viral diseases.